MERCK & CO., INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 114.71 USD | -0.54% |
|
-0.94% | +5.22% |
| 11/09 | Merck: positive results for HPV vaccine | CF |
| 11/09 | Merck's HPV Vaccine Meets Main Goal in Phase 3 Study in Japanese Males | MT |
Main competitors
| Composite Fundamentals | Composite Valuation | Composite Consensus | Composite Momentum | Composite Visibility | Investor Rating | ESG Refinitiv | Capi. ($) | ||
|---|---|---|---|---|---|---|---|---|---|
B- | 29TCr | ||||||||
C+ | 83TCr | ||||||||
B | 58TCr | ||||||||
C+ | 40TCr | ||||||||
C+ | 34TCr | ||||||||
A+ | 25TCr | ||||||||
B+ | 25TCr | ||||||||
B- | 23TCr | ||||||||
C+ | 18TCr | ||||||||
C+ | 17TCr | ||||||||
B+ | 14TCr | ||||||||
B- | 10TCr | ||||||||
B | 9.85TCr | ||||||||
B | 8.79TCr | ||||||||
A- | 7.54TCr | ||||||||
A- | 6.99TCr | ||||||||
B+ | 4.7TCr | ||||||||
B | 4.68TCr | ||||||||
B | 4.06TCr | ||||||||
| Average | B | 22.29TCr | |||||||
| Weighted average by Cap. | B |
- Stock Market
- Equities
- MRK Stock
- Sector Merck & Co., Inc.
- Sector ratings
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition